Search

Search Constraints

You searched for: Author/Creator Chuganji, Yoshimichi

Search Results

1. A 48‐week telaprevir‐based triple combination therapy improves sustained virological response rate in previous non‐responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study. Issue 14 (15th April 2014)

2. Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema. Issue 6 (19th February 2018)

4. Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease. Issue 11 (12th April 2017)

5. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. Issue 5 (17th September 2015)

6. Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease. Issue 7 (21st February 2018)

7. Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C. Issue 13 (30th May 2017)

9. Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype. Issue 4 (18th July 2014)

10. ITPA gene variation and ribavirin‐induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Issue 11 (7th March 2017)